Holdings (Monthly)
Guide ↗
iShares U.S. Healthcare ETF
· iShares Trust| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 066922519 | Jan 2026 | 28,452,124 | +17,351,168 | $28.5M | +156.3% | 0.80% | STIV |
| 2 | WATERS CORPORATION | 941848103 | Jan 2026 | 57,652 | +21,886 | $21.8M | +64.1% | 0.61% | EC |
| 3 | NATERA, INC. | 632307104 | Jan 2026 | 80,150 | +2,255 | $21.5M | +19.2% | 0.60% | EC |
| 4 | REVOLUTION MEDICINES, INC. | 76155X100 | Jan 2026 | 112,298 | +8,154 | $21.1M | +108.6% | 0.59% | EC |
| 5 | ALNYLAM PHARMACEUTICALS, INC. | 02043Q107 | Jan 2026 | 78,219 | +2,076 | $16.1M | -37.5% | 0.45% | EC |
| 6 | ROYALTY PHARMA PLC | G7709Q104 | Jan 2026 | 242,806 | +9,455 | $14.2M | +45.9% | 0.40% | EC |
| 7 | INSMED INCORPORATED | 457669307 | Jan 2026 | 125,910 | +109 | $12.4M | -37.1% | 0.35% | EC |
| 8 | INCYTE CORPORATION | 45337C102 | Jan 2026 | 97,220 | +972 | $11.6M | +20.6% | 0.33% | EC |
| 9 | Roivant Sciences Ltd | G76279101 | Jan 2026 | 287,093 | +53,586 | $9.7M | +92.8% | 0.27% | EC |
| 10 | NEUROCRINE BIOSCIENCES, INC. | 64125C109 | Jan 2026 | 58,123 | +1 | $9.7M | +22.6% | 0.27% | EC |
| 11 | JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY | G50871105 | Jan 2026 | 35,041 | +106 | $8.9M | +54.2% | 0.25% | EC |
| 12 | MEDPACE HOLDINGS, INC. | 58506Q109 | Jan 2026 | 13,539 | +124 | $7.8M | -0.0% | 0.22% | EC |
| 13 | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 066922477 | Jan 2026 | 5,103,577 | +2,395,136 | $5.1M | +88.4% | 0.14% | STIV |
| 14 | IONIS PHARMACEUTICALS, INC. | 462222100 | Jan 2026 | 96,552 | +1,675 | $5.0M | -36.3% | 0.14% | EC |
| 15 | BRUKER CORPORATION | 116794108 | Jan 2026 | 65,029 | +3,186 | $4.1M | +49.2% | 0.11% | EC |
| 16 | SOTERA HEALTH COMPANY | 83601L102 | Jan 2026 | 163,056 | +40,405 | $2.9M | +31.0% | 0.08% | EC |
| 17 | TEMPUS AI, INC. | 88023B103 | Jan 2026 | 63,023 | +5,435 | $2.8M | -19.7% | 0.08% | EC |
| 18 | Viking Therapeutics Inc | 92686J106 | Jan 2026 | 66,422 | +1,209 | $2.1M | +11.3% | 0.06% | EC |
| 19 | CARIS LIFE SCIENCES, INC. | 142152107 | Jan 2026 | 72,309 | +58,965 | $1.1M | +266.6% | 0.03% | EC |
| 20 | Summit Therapeutics Inc | 86627T108 | Jan 2026 | 79,256 | +9,387 | $1.0M | +2.0% | 0.03% | EC |
| 21 | XAV HEALTH CARE SEP26 | 1XAVU26 | Jan 2026 | 50 | +7 | $246K | -410.8% | 0.01% | DE |